Literature DB >> 14734719

Lck is required for activation-induced T cell death after TCR ligation with partial agonists.

Xue-Zhong Yu1, Steven D Levin, Joaquin Madrenas, Claudio Anasetti.   

Abstract

TCR engagement can induce either T cell proliferation and differentiation or activation-induced T cell death (AICD) through apoptosis. The intracellular signaling pathways that dictate such a disparate fate after TCR engagement have only been partially elucidated. Non-FcR-binding anti-CD3 mAbs induce a partial agonist TCR signaling pattern and cause AICD on Ag-activated, cycling T cells. In this study, we examined TCR signaling during the induction of AICD by anti-CD3 fos, a non-FcR-binding anti-CD3 mAb. This mAb activates Fyn, Lck, and extracellular signal-regulated kinase, and induces phosphorylation of Src-like adapter protein, despite the inability to cause calcium mobilization or TCR polarization. Anti-CD3 fos also fails to effectively activate zeta-associated protein of 70 kDa or NF-kappaB. Using Ag-specific T cells deficient for Fyn or Lck, we provide compelling evidence that activation of Lck is required for the induction of AICD. Our data indicate that a selective and distinct TCR signaling pattern is required for AICD by TCR partial agonist ligands.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734719     DOI: 10.4049/jimmunol.172.3.1437

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Bim is required for T-cell allogeneic responses and graft-versus-host disease in vivo.

Authors:  Yu Yu; Jing Yu; Cristina Iclozan; Kane Kaosaard; Claudio Anasetti; Xue-Zhong Yu
Journal:  Am J Blood Res       Date:  2012-01-01

2.  Ca2+-dependent protein acyltransferase DHHC21 controls activation of CD4+ T cells.

Authors:  Shayahati Bieerkehazhi; Ying Fan; Savannah J West; Ritika Tewari; Junsuk Ko; Tingting Mills; Darren Boehning; Askar M Akimzhanov
Journal:  J Cell Sci       Date:  2021-06-03       Impact factor: 5.235

3.  The glycerophosphoinositols: from lipid metabolites to modulators of T-cell signaling.

Authors:  Laura Patrussi; Stefania Mariggiò; Daniela Corda; Cosima T Baldari
Journal:  Front Immunol       Date:  2013-07-29       Impact factor: 7.561

4.  Comprehensive transcriptomic analysis shows disturbed calcium homeostasis and deregulation of T lymphocyte apoptosis in inclusion body myositis.

Authors:  Mridul Johari; Anna Vihola; Johanna Palmio; Manu Jokela; Per Harald Jonson; Jaakko Sarparanta; Sanna Huovinen; Marco Savarese; Peter Hackman; Bjarne Udd
Journal:  J Neurol       Date:  2022-03-02       Impact factor: 6.682

5.  Functional characterization of N297A, a murine surrogate for low-Fc binding anti-human CD3 antibodies.

Authors:  Debra T Chao; Xiaohong Ma; Olga Li; Hyunjoo Park; Debbie Law
Journal:  Immunol Invest       Date:  2009       Impact factor: 3.657

6.  Anti-CD3 antibody treatment induces hypoglycemia and super tolerance to glucose challenge in mice through enhancing glucose consumption by activated lymphocytes.

Authors:  Chang-Qing Xia; Anna V Chernatynskaya; Benjamin Looney; Suigui Wan; Michael J Clare-Salzler
Journal:  J Immunol Res       Date:  2014-02-11       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.